More than 250 000 individuals undergo ambulatory endoscopic sinus surgery for chronic rhinosinusitis each year. Although estimates vary, up to one-fifth of these patients may undergo revision surgery for symptoms secondary to formation of adhesions, recurrent polyposis, and persistent inflammation.1 In an effort to limit the use of revision surgery, otolaryngologists have used postoperative adjunct treatments such as packing materials and oral corticosteroid therapy.
Gadkaree SK, Rathi VK, Scangas GA, Naunheim MR, Metson R. Use of Corticosteroid-Eluting Sinus Stents Between 2012 and 2017. JAMA Otolaryngol Head Neck Surg. Published online November 15, 2018. doi:10.1001/jamaoto.2018.2944
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: